Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-06

Clinical Trial Update: Anthocyanin-Rich Table Grape Powder for Prophylaxis of Post-Operative Atrial Fibrillation [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating anthocyanin-rich table grape powder to prevent postoperative atrial fibrillation and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Anthocyanin-Rich Table Grape Powder

Snippet

Sponsor: University of Michigan | Conditions: Post-operative Atrial Fibrillation (POAF) | Phase 1, Phase 2 | Status: RECRUITING